1. Home >
  2. M&A >
  3. Secondary Buyout >
  4. Germany >
  5. IK Partners Acquires Ondal Group

M&A Deal Summary

IK Partners Acquires Ondal Group

On December 3, 2019, private equity firm IK Partners acquired medical products company Ondal Group from Capvis

Acquisition Highlights
  • This is IK Partners’ 7th transaction in the Medical Products sector.
  • This is IK Partners’ 20th transaction in Germany.

M&A Deal Summary
Date 2019-12-03
Target Ondal Group
Sector Medical Products
Buyer(s) IK Partners
Sellers(s) Capvis
Deal Type Secondary Buyout
Advisor(s) William Blair (Financial)
Hengeler Mueller (Legal)

Target

Ondal Group

Hunfeld, Germany
Ondal Group is a developer and manufacturer of medical pendant systems that facilitate movement, support loads and supply medical equipment with light, gas or data. Ondal sets the global quality standard for medical pendant systems in terms of reliability, functionality, and usability. Products manufactured by Ondal are internationally certified in various regulated markets, ensuring compliance with the highest quality standards. Ondal Group was founded in 1945 and is based in Hunfeld, Germany.

Search 205,615 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IK Partners

London, United Kingdom

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1989
PE ASSETS 14.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

IK Partners is a private equity firm that targets control investments in lower middle-market to large-sized companies throughout Europe. IK focuses on growth businesses located in the Benelux region, as well as Denmark, Finland, France, Germany, Norway and Sweden. The Firm looks to commit €10 to €300 million of equity capital per transaction and targets companies with strong cash-flows. IK Investment Partners was formerly known as Industry Kapital. IK Partners was formed in 1989 and is based in London, England.

DEAL STATS #
Overall 135 of 187
Sector (Medical Products) 7 of 7
Type (Secondary Buyout) 46 of 73
Country (Germany) 20 of 26
Year (2019) 7 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-26 Mabtech

Nacka Strand, Sweden

Mabtech is a biotech company specialising in immune monitoring products used by companies and researchers on a global scale. Mabtech was founded in 1986 and is based in Nacka Strand, Sweden.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-19 Cerelia

Paris, France

Cerelia is a provider of innovative bakery solutions with a product portfolio including ready-to-bake pie and pizza dough, pancakes, crepes, and cookies. Cerelia was founded in 1999 and is based in Paris, France.

Sell -

Seller(S) 1

SELLER

Capvis

Baar, Switzerland

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1990
PE ASSETS 3.9B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Capvis Equity Partners is a Swiss-based private equity firm focused on buyout, succession, and expansion investments in Switzerland, China, and Germany. Sectors of interest include Healthcare, Industrial Technology, and Advanced Services & Software. Capvis will consider both majority and minority positions. The Firm's investment horizon is four to six years. Capvis Equity Partners was formed in 1990 and is headquartered in Baar with additional offices in Germany and China.

DEAL STATS #
Overall 32 of 35
Sector (Medical Products) 2 of 2
Type (Secondary Buyout) 7 of 8
Country (Germany) 7 of 8
Year (2019) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-15 Xovis

Zollikofen, Switzerland

Xovis is a high-tech company that develops and commercializes systems and sensors for people counting, tracking and similar applications. Xovis solutions are used for the optimised control of passenger flows and waiting times, for example at airports or in stationary retail. Xovis was founded in 2008 and is based in Zollikofen, Switzerland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-13 Tertianum

Zurich, Switzerland

Tertianum is an elderly care service provider in Switzerland offering inpatient care as well as assisted living services. The company has 80 locations, with approx. 3'400 care beds and more than 2'000 apartments for assisted living. Tertianum offers several specialized care services, such as dementia, geriatric care, palliative care, or other therapies. Tertianum was founded in 1982 and is based in Zurich, Switzerland.

Buy -
Mergr

Product

Company

Legal